Category Archives: Taxotere

Featured Stories

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

E. District of Missouri denied motion to dismiss conspiracy claims. Lawsuit alleges the defendants conspired to misrepresent true dangers with use of talcum powder.

Read More

System for Tracking Prescription Drug Side Effects Flawed

Study Finds System for Tracking Prescription Drug Side Effects Flawed

System for keeping track of dangerous side effects of prescription drugs is flawed because drug makers are submitting incomplete information about problems to the FDA.

Read More

1,000+ Australians Join DePuy ASR Hip Implant Class Action Lawsuit

A class action lawsuit filed in Australia over DePuy Orthopaedics’ recalled metal-on-metal ASR Hip Implants has signed up more than 1,000 plaintiffs. The attorneys representing the Australian ASR Hip Implant lawsuit plaintiffs recently told The Courier-Mail that damages in the lawsuit are expected to be worth more than $200 million. One ...

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Woman Alleges Permanent Alopecia after Using Taxotere Chemotherapy Drug

Woman Alleges Permanent Alopecia after Using Taxotere

Sanofi-Aventis is facing another lawsuit over its chemotherapy drug, Taxotere. A woman alleges that the company failed to warn about the risk of permanent alopecia, or hair loss, after taking Taxotere. She alleges that the company misled her and her … Continue reading

Posted in Pharmaceuticals, Taxotere | Tagged , , , , |

New Lawsuit Filed over Taxotere Alleges Permanent Hair Loss

New Lawsuit Filed over Taxotere Alleges Permanent Hair Loss

Sanofi-Aventis is facing a new lawsuit filed over Taxotere, a chemotherapy drug used to treat breast cancer and other forms of cancer. The suit, filed on behalf of a Mississippi woman, alleges that the drug resulted in alopecia, or permanent … Continue reading

Posted in Pharmaceuticals, Taxotere | Tagged , , , , , , |

Lawsuits Filed when Permanent Chemotherapy Hair Loss is Linked to Taxotere

Lawsuits Filed For Chemotherapy Hair Loss Link to Taxotere

Breast cancer patients are usually familiar with the likely side effect of chemotherapy of hair loss.  Most, however, expect that hair grows back once the chemotherapy is over. However, an increasing number of breast cancer patients are finding that this is … Continue reading

Posted in Health Concerns, Pharmaceuticals, Taxotere | Tagged , , , , , , |

Sanofi Faces Another Lawsuit over Taxotere

Sanofi Faces Another Lawsuit over Taxotere

Sanofi-Aventis faces another lawsuit alleging that its chemotherapy drug Taxotere led to permanent hair loss, or alopecia. The suit accuses the drug maker of failing to adequately warn about the risk of irreversible hair loss. The plaintiff is a California … Continue reading

Posted in Pharmaceuticals, Taxotere | Tagged , , , , , , , , , , , , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.